Cellular pathways involved in nerve regeneration

Cellular pathways involved in nerve regeneration encompass a diverse set of intracellular signaling cascades and gene expression programs that facilitate the repair and regrowth of neurons following injury (Mahar & Cavalli, 2018, Nature Reviews Neuroscience). These pathways are categorized into intrinsic mechanisms, which govern the neuron's internal capacity for growth, and extrinsic mechanisms, which involve the response to the surrounding environment, such as the glial scar or myelin-associated inhibitors (He & Jin, 2016, Neuron). Key pathways include the PI3K/Akt/mTOR axis, which is a central regulator of protein synthesis and axonal elongation, and the JAK/STAT3 pathway, which responds to injury-induced cytokines and growth factors (Park et al., 2008, Science). In the central nervous system, regeneration is often halted by inhibitory molecules like Nogo-A and Chondroitin Sulfate Proteoglycans (CSPGs) that signal through the RhoA/ROCK pathway to cause growth cone collapse (Silver & Miller, 2004, Nature Reviews Neuroscience). The DLK/JNK pathway also plays a critical role as an injury sensor, initiating the regenerative response in the peripheral nervous system (Watkins et al., 2013, Neuron). Therapeutic strategies focus on modulating these pathways, such as using mTOR activators or RhoA inhibitors, to overcome the inhibitory environment and enhance the neuron's innate growth potential. Despite promising preclinical results, translating these findings into clinical treatments for spinal cord injury and neurodegenerative diseases remains a significant challenge due to the complexity of the signaling networks involved. Safety concerns include the potential for tumorigenesis when activating potent growth pathways and the risk of maladaptive plasticity leading to neuropathic pain.

Other names

Axonal regeneration pathwaysNerve repair mechanismsNeuroregeneration signaling cascadesIntrinsic growth pathways

Modulation of intrinsic neuronal growth capacity (e.g., via PTEN/mTOR) and neutralization of extrinsic inhibitory signals (e.g., via RhoA inhibition) to promote axonal elongation and functional recovery (He & Jin, 2016, Neuron).